The increasing amount of clinically relevant information obtained by positron emission
tomography (PET), primarily with fluorine-18 labelled 2-deoxy-2-fluoro-d-glucose, has …

This is a time of rapid change in the evolution of clinical positron imaging systems, spurred
by the wider availability of 18F-fluorodeoxyglucose, continued increase in clinical research …

This is the first article of a four-part series on positron emission tomography (PET). Upon
completing the article, the reader should be able to:(1) comprehend the basic principles of …

Up to a few years ago, positron emission tomography (PET) was known as a very expensive
research tool using positron emitting radiopharmaceuticals to study metabolic processes in …

This report has emphasized the attributes of positron emission tomography (PET) through a
discussion of the historical development with attention to limitations or factors that are of …

Positron emission tomography (PET) is a method by which the in vivo distribution of a
radiopharmaceutical can be measured with high resolution and sensitivity. Conventional …

Optimized positron emission tomographs have begun to demonstrate an ever widening
range of clinical applications for positron labelled pharmaceuticals. This potential has led to …

The developments in positron emission tomography (PET) are reviewed with an emphasis
on instrumentation for clinical PET imaging. After a brief summary of positron imaging before …

Positron emission tomography (PET) is a functional imaging technique introduced in 1970s.
Over the years, PET was used alone but is in 2000 when the first hybrid PET/CT device was …

Line-source experiments were conducted to assess the performance of a gamma-camera
equipped with a specially designed 511-keV collimator for the planar imaging of positron …